[HTML][HTML] One-year post-primary antibody persistence and booster immune response to a fully liquid five-component acellular pertussis, diphtheria, tetanus, inactivated …

TY Lin, YH Wang, YC Huang, CH Chiu, PY Lin… - International journal of …, 2007 - Elsevier
OBJECTIVE: To evaluate antibody persistence one year after three-dose primary
vaccination and booster immune response during the second year of life for a fully liquid …

Antibody persistence against diphtheria, tetanus, pertussis, poliomyelitis and Haemophilus influenzae type b (Hib) in 5–6-year-old children after primary vaccination …

E Mallet, N Matisse, N Mathieu, J Langue, F Boisnard… - Vaccine, 2004 - Elsevier
The main objective of this study was to assess in 5–6-year-old French children (n= 234) the
persistence of antibodies induced by a primary series vaccination (at 2–4 months of age) …

Antibody persistence to diphtheria toxoid, tetanus toxoid, Bordetella pertussis antigens, and Haemophilus influenzae type b following primary and first booster with …

N Wanlapakorn, N Sarawanangkoor… - Human Vaccines & …, 2024 - Taylor & Francis
Thailand has incorporated the whole-cell (wP) pertussis vaccine into the expanded program
on immunization since 1977 and has offered the acellular pertussis (aP) vaccine as an …

Persistence of antibodies at 5–6 years of age for children who had received a primary series vaccination with a pentavalent whole-cell pertussis vaccine and a first …

J Langue, N Matisse, P Pacoret, F Undreiner… - Vaccine, 2004 - Elsevier
The main objective of this study was to assess in 5–6-year-old French children (n= 162) the
persistence of antibodies induced by a primary series vaccination (at 2–4 months of age) …

Safety and Immunogenicity of a Fully Liquid Vaccine Containing Five‐Component Pertussis‐Diphtheria‐Tetanus‐Inactivated Poliomyelitis‐Haemophilus influenzae …

R Gold, L Barreto, S Ferro… - Canadian Journal of …, 2007 - Wiley Online Library
OBJECTIVE: The safety, immunogenicity and lot consistency of a fully liquid, five‐component
acellular pertussis combination vaccine, comprised of diphteria, tetanus and acellular …

[HTML][HTML] A fully liquid diphtheria–tetanus–five component acellular pertussis–inactivated poliomyelitis–Haemophilus influenzae type b conjugate vaccine …

TY Lin, YH Wang, LY Chang, YC Huang, HT Kao… - International journal of …, 2007 - Elsevier
OBJECTIVE: To assess the immunogenicity of a fully liquid diphtheria–tetanus–five
component acellular pertussis–inactivated poliomyelitis–Haemophilus influenzae type b …

Immunogenicity and reactogenicity of a booster dose of diphtheria, tetanus, acellular pertussis and inactivated poliomyelitis vaccines given concurrently with …

P Begue, J Stagnara, F Vie-Le-Sage… - The Pediatric …, 1997 - journals.lww.com
Background. The high reactogenicity of whole cell pertussis vaccines discourages their use
in children. While acellular pertussis vaccines are less reactogenic, their use in diphtheria …

Randomized, Controlled, Multicenter Study of the Immunogenicity and Safety of a Fully Liquid Combination Diphtheria–Tetanus Toxoid–Five-Component Acellular …

T Vesikari, SA Silfverdal, F Boisnard… - Clinical and Vaccine …, 2013 - Am Soc Microbiol
This study compared the levels of immunogenicity and safety of diphtheria–tetanus toxoid–
five-component acellular pertussis (DTaP5), inactivated poliovirus (IPV), and Haemophilus …

Safety and immunogenicity of a combined diphtheria-tetanus-acellular pertussis-inactivated polio vaccine-Haemophilus influenzae type b vaccine administered at 2-4 …

RM Carlsson, BA Claesson, U Selstam… - The Pediatric …, 1998 - journals.lww.com
Methods. In an open randomized study we compared the safety and immunogenicity of two
schedules for priming and booster vaccinations of infants. A pentavalent combination …

Antibody Persistence Following Administration of a Hexavalent DTwP-IPV-HB-PRP~ T Vaccine Versus Separate DTwP-HB-PRP~ T and IPV Vaccines and Safety and …

S Mangarule, P Siddaiah, A Kawade… - The Pediatric …, 2023 - journals.lww.com
Background: Antibody persistence of a whole-cell pertussis-containing hexavalent vaccine
(DTwP-IPV-HB-PRP~ T) and its co-or sequential administration with measles, mumps …